480 related articles for article (PubMed ID: 17560176)
1. ENaCbeta and gamma genes as modifier genes in cystic fibrosis.
Viel M; Leroy C; Hubert D; Fajac I; Bienvenu T
J Cyst Fibros; 2008 Jan; 7(1):23-9. PubMed ID: 17560176
[TBL] [Abstract][Full Text] [Related]
2. Genotype-phenotype correlation for pulmonary function in cystic fibrosis.
de Gracia J; Mata F; Alvarez A; Casals T; Gatner S; Vendrell M; de la Rosa D; Guarner L; Hermosilla E
Thorax; 2005 Jul; 60(7):558-63. PubMed ID: 15994263
[TBL] [Abstract][Full Text] [Related]
3. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.
Salvatore F; Scudiero O; Castaldo G
Am J Med Genet; 2002 Jul; 111(1):88-95. PubMed ID: 12124743
[TBL] [Abstract][Full Text] [Related]
4. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
[TBL] [Abstract][Full Text] [Related]
5. Disease modifying genes in cystic fibrosis.
Slieker MG; Sanders EA; Rijkers GT; Ruven HJ; van der Ent CK
J Cyst Fibros; 2005 Aug; 4 Suppl 2():7-13. PubMed ID: 15996905
[TBL] [Abstract][Full Text] [Related]
6. The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation.
Chiba-Falek O; Kerem E; Shoshani T; Aviram M; Augarten A; Bentur L; Tal A; Tullis E; Rahat A; Kerem B
Genomics; 1998 Nov; 53(3):276-83. PubMed ID: 9799593
[TBL] [Abstract][Full Text] [Related]
7. Genetic modifiers of lung disease in cystic fibrosis.
Drumm ML; Konstan MW; Schluchter MD; Handler A; Pace R; Zou F; Zariwala M; Fargo D; Xu A; Dunn JM; Darrah RJ; Dorfman R; Sandford AJ; Corey M; Zielenski J; Durie P; Goddard K; Yankaskas JR; Wright FA; Knowles MR;
N Engl J Med; 2005 Oct; 353(14):1443-53. PubMed ID: 16207846
[TBL] [Abstract][Full Text] [Related]
8. Modifier genes in cystic fibrosis lung disease.
Merlo CA; Boyle MP
J Lab Clin Med; 2003 Apr; 141(4):237-41. PubMed ID: 12677168
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India.
Shastri SS; Kabra M; Kabra SK; Pandey RM; Menon PS
J Cyst Fibros; 2008 Mar; 7(2):110-5. PubMed ID: 17716958
[TBL] [Abstract][Full Text] [Related]
10. Association between genotype and pulmonary phenotype in cystic fibrosis patients with severe mutations.
Geborek A; Hjelte L
J Cyst Fibros; 2011 May; 10(3):187-92. PubMed ID: 21354377
[TBL] [Abstract][Full Text] [Related]
11. Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis.
Choi EH; Ehrmantraut M; Foster CB; Moss J; Chanock SJ
Pediatr Pulmonol; 2006 Mar; 41(3):255-62. PubMed ID: 16429424
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease.
Azad AK; Rauh R; Vermeulen F; Jaspers M; Korbmacher J; Boissier B; Bassinet L; Fichou Y; des Georges M; Stanke F; De Boeck K; Dupont L; Balascáková M; Hjelte L; Lebecque P; Radojkovic D; Castellani C; Schwartz M; Stuhrmann M; Schwarz M; Skalicka V; de Monestrol I; Girodon E; Férec C; Claustres M; Tümmler B; Cassiman JJ; Korbmacher C; Cuppens H
Hum Mutat; 2009 Jul; 30(7):1093-103. PubMed ID: 19462466
[TBL] [Abstract][Full Text] [Related]
13. Genotype-phenotype correlation in cystic fibrosis patients.
Ferrari M; Cremonesi L
Ann Biol Clin (Paris); 1996; 54(6):235-41. PubMed ID: 8949420
[TBL] [Abstract][Full Text] [Related]
14. Modifier effect of the Toll-like receptor 4 D299G polymorphism in children with cystic fibrosis.
Urquhart DS; Allen J; Elrayess M; Fidler K; Klein N; Jaffé A
Arch Immunol Ther Exp (Warsz); 2006; 54(4):271-6. PubMed ID: 16830219
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
16. Diversity of the basic defect of homozygous CFTR mutation genotypes in humans.
Stanke F; Ballmann M; Bronsveld I; Dörk T; Gallati S; Laabs U; Derichs N; Ritzka M; Posselt HG; Harms HK; Griese M; Blau H; Mastella G; Bijman J; Veeze H; Tümmler B
J Med Genet; 2008 Jan; 45(1):47-54. PubMed ID: 18178635
[TBL] [Abstract][Full Text] [Related]
17. Familial concordance of phenotype and microbial variation among siblings with CF.
Picard E; Aviram M; Yahav Y; Rivlin J; Blau H; Bentur L; Avital A; Villa Y; Schwartz S; Kerem B; Kerem E
Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype relationship for five CFTR mutations frequently identified in western France.
Duguépéroux I; De Braekeleer M;
J Cyst Fibros; 2004 Dec; 3(4):259-63. PubMed ID: 15698945
[TBL] [Abstract][Full Text] [Related]
19. Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3' enhancer polymorphism in alpha-1-antitrypsin.
Courtney JM; Plant BJ; Morgan K; Rendall J; Gallagher C; Ennis M; Kalsheker N; Elborn S; O'Connor CM
Pediatr Pulmonol; 2006 Jun; 41(6):584-91. PubMed ID: 16617455
[TBL] [Abstract][Full Text] [Related]
20. Clinical phenotype of cystic fibrosis patients with the G551D mutation.
Comer DM; Ennis M; McDowell C; Beattie D; Rendall J; Hall V; Elborn JS
QJM; 2009 Nov; 102(11):793-8. PubMed ID: 19734299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
